Eli Lilly (NY:LLY)

As November 2025 unfolds, the global financial markets find themselves at a critical juncture, characterized by a palpable sense of unease over elevated valuations in specific sectors and a pronounced...

Topics Artificial Intelligence Economy

Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation

Today 10:23 EST

Nvidia and 19 Other Stocks Now Make Up 50% of the S&P 500. Here's What It Means for Your Investment Portfolio. ↗

Topics Artificial Intelligence Bonds Economy

Today 9:52 EST

Buying the S&P 500 takes the belief that today's leading companies deserve their lofty valuations.

Novo Nordisk undercut Eli Lilly and the Trump administration on Monday, slashing the cash price of its Wegovy and Ozempic.

Topics Stocks

How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration ↗

Today 9:44 EST

Via Investor's Business Daily

Topics Government

White House Economic Advisor Kevin Hassett Says India Trade Deal Talks Got ‘Pretty Complicated’, But Remains Hopeful: Report ↗

Today 8:43 EST

In an interview with CNBC, Hassett remained optimistic about striking an agreement with India, but added that there are a lot of different variables in the India-U.S. relationship.

Novo Nordisk Offers WeGovy, Ozempic For $199 A Month As It Takes On Eli Lilly’s Zepbound ↗

Today 8:14 EST

The Danish drugmaker has announced that this offer is applicable to cash-paying patients looking to purchase introductory doses of Wegovy and Ozempic.

Healthcare stocks have far outperformed the broader market over the past month.

Topics Artificial Intelligence

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗

Today 5:25 EST

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Topics ETFs Government World Trade

2 Mooning Stocks to Keep an Eye On and 1 We Ignore

November 16, 2025

Via StockStory

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? ↗

November 16, 2025

Investors will be watching what Trump makes happen.

Drugs for weight loss and diabetes are taking Eli Lilly to new heights.

Topics Government

Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock ↗

November 16, 2025

Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗

November 16, 2025

Ten large-cap standouts—including Maplebear, Tower Semiconductor, Eli Lilly, On Holding, Albemarle, and key gold/silver miners—rallied last week on strong earnings, upbeat guidance, analyst upgrades,...

Via Benzinga

Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗

November 15, 2025

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize.

Via Benzinga

Topics ETFs

Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗

November 14, 2025

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven asset allocation.

Via Benzinga

Government Reopens, AI Stocks Slide On Supply Crunch Fears: This Week In Markets ↗

November 14, 2025

Markets digest U.S. government reopening, hawkish Fed outlook, and AI sell-off as CoreWeave crashes 25%.

Via Benzinga

Topics Artificial Intelligence Economy

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Via Benzinga

Topics Artificial Intelligence

Novo Nordisk Brings Back Former CEO To Lead Board ↗

November 14, 2025

Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.

Topics Artificial Intelligence Economy Intellectual Property

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since ↗

November 14, 2025

Via MarketBeat

Ozempic Maker Novo Nordisk Faces Board Shakeup ↗

November 14, 2025

Via Benzinga

Why Is Everyone Talking About Novo Nordisk Stock? ↗

November 14, 2025

There is hardly a dull moment for the drugmaker these days.

Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗

November 14, 2025

The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction.

Immuneering (IMRX) Q3 2025 Earnings Transcript

Immuneering (IMRX) Q3 2025 Earnings Transcript ↗

November 13, 2025

The United States government has recently emerged from its longest shutdown in history, a 43-day impasse that concluded on November 12, 2025. This protracted closure plunged the nation into an...

Topics Intellectual Property

Post-Shutdown Data Deluge: Markets Brace for Economic Reckoning as US Government Reopens

November 13, 2025

Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs ↗

Topics Credit Cards Economy World Trade

November 13, 2025

The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.

These top growth stocks have plenty of room left to run.

Here Are the Top Growth Healthcare Stocks Every New Investor Should Know ↗

November 13, 2025

2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors ↗

November 13, 2025

Healthcare stocks have plenty to offer new investors.

Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.

1 Incredible Reason to Buy LLY's Stock in November ↗

November 13, 2025

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗

Topics Government World Trade

November 13, 2025

Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

November 12, 2025

Via StockStory

Eli Lilly Soars: A Pharmaceutical Giant's Breakout Fueled by Blockbuster Drugs and Strategic Vision

November 12, 2025

INDIANAPOLIS, IN – November 12, 2025 – Eli Lilly and Company (NYSE: LLY) is experiencing a monumental stock breakout today, sending ripples across the global financial markets. The pharmaceutical...